Abstract

Intraductal radiofrequency (RF) ablation combined with placement of a self-expandable metal stent (SEMS) for malignant biliary obstruction has risks such as stent- and heat-induced biliary sludge and restenosis. Here, we investigated the efficacy of a silver nanoparticles (AgNPs)-coated SEMS to inhibit tissue hyperplasia and bacterial growth caused by RF ablation with stent placement in the rabbit bile duct. The release behavior and antibacterial effects of AgNPs-coated SEMSs were evaluated. Then, SEMSs were successfully placed in all rabbits immediately after RF ablation. Ag ions were rapidly released at the beginning and then showed a gradual release behavior. The AgNPs-coated SEMS significantly inhibited bacterial activity compared to the uncoated SEMS (p < 0.05). Cholangiography and histological examination confirmed that the level of tissue hyperplasia was significantly lower in the AgNPs group than in the control group (all p < 0.05). Immunohistochemistry analyses revealed that TUNEL-, HSP 70-, and α-SMA-positive areas were significantly lower in the AgNPs group than in the control group (all p < 0.05). Intraductal RF ablation combined with nanofunctionalized stent placement represents a promising new approach for suppressing thermal damage as well as stent-induced tissue hyperplasia and bacterial growth.

Highlights

  • Introduction iationsMalignant biliary obstruction (MBO) is caused by various factors, including cholangiocarcinoma, pancreatic cancer, extrinsic compression, and adjacent inflammation

  • AgNPs-coated self-expandable metal stent (SEMS) were successfully fabricated through a two-step simple synthesis process

  • Elemental analysis through energy-dispersive X-ray spectroscopy revealed that the atomic percentage of Ag was 0% in uncoated SEMS and 11.8% in AgNPs-coated SEMS (Figure 2a–c)

Read more

Summary

Introduction

Malignant biliary obstruction (MBO) is caused by various factors, including cholangiocarcinoma, pancreatic cancer, extrinsic compression, and adjacent inflammation. As. MBO is often diagnosed at a later stage, the proportion of patients who undergo surgical resection is limited to only 30%, resulting in a high mortality rate [1–4]. Placement of a selfexpandable metal stent (SEMS) is the current standard treatment for palliation in patients with unresectable MBO [5–8]. SEMSs are susceptible to recurrent symptoms due to tumor ingrowth, tissue hyperplasia, biofilm deposition, and biliary sludge formation with restenosis, which occur within 6 to 8 months [5,8–10]. Ablation has been presented as a novel option for the palliative management of unresectable. RF ablation generates high-frequency alternating currents to create localized heating and induce coagulative necrosis in tumor tissues, maintaining patency

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call